Nkarta is a biopharmaceutical company headquartered in South San Francisco, California, positioned centrally within the prominent biotechnology and life sciences cluster of the San Francisco Bay Area. This regional hub grants the company immediate access to top-tier scientific talent, venture capital networks, and collaborative academic research institutions. From this corporate location, executive management and laboratory teams direct the ongoing development of proprietary cell therapy pipelines designed to address complex oncology and autoimmune indications.